Brief: Enochian Biosciences Announces Its Successful Completion Of FDA Pre-IND For Potential Cure For Hepatitis B Virus Infection
Sept 27 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES ANNOUNCES ITS SUCCESSFUL COMPLETION
OF FDA
PRE-IND FOR A POTENTIAL CURE FOR HEPATITIS B VIRUS INFECTION
Source text for Eikon: ID:nGNX5hLS0k
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing